ANM Mo99 and ANSTO SyMo facility siting licence applications

7 May 2013

Invitation to make submissions on facility licence applications under the Australian Radiation Protection and Nuclear Safety Act 1998

The CEO of ARPANSA intends making a decision under section 32 of the Australian Radiation Protection and Nuclear Safety Act 1998 on a facility licence application by the Australian Nuclear Science and Technology Organisation (ANSTO) in respect of the following nuclear installation:

ANSTO Nuclear Medicine Molybdenum-99 Facility (ANM Mo99)
Application Number A0270 to prepare a site for the proposed ANM Mo99 at the Lucas Heights Science and Technology Centre in Menai, New South Wales. The proposed facility will be for the production of Molybdenum-99 to be used in nuclear medicine.

The CEO of ARPANSA also intends making a decision on an associated prescribed radiation facility application for the ANSTO SyMo Facility. The application is provided below to ensure the public can provide informed submissions on the ANM Mo99 licence application. For further information on these applications see Application information.

A community information session was held on Thursday 16 May at 6pm in Hall 1, Engadine Community Centre, 1034-1036 Old Princes Highway, Engadine, NSW.

FileCommunity information session program

In accordance with Regulation 40 of the Australian Radiation Protection and Nuclear Safety Regulations 1999, the CEO of ARPANSA invited submissions about the applications. The CEO takes all submissions into account before making a decision on whether or not to grant the facility licences.

Submissions closed on Wednesday 12 June 2013.

Top of Page

Licence applications and supporting information

Application Number A0270 - ANSTO nuclear medicine molybdenum-99 facility (ANM Mo99)

Siting licence application

Plans & arrangements

SAC assessment documents

Additional documents

Application number A0266 - ANSTO SyMo facility

Plans & arrangements

Other documents


These documents are provided in PDF format only. If you can not access PDFs, please contact us for access to an alternative version of the information.